Clinical Trial Update: Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the role of the noradrenergic system in pain perception in Parkinson's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED